HUP9900580A3 - 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity - Google Patents

2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity

Info

Publication number
HUP9900580A3
HUP9900580A3 HU9900580A HUP9900580A HUP9900580A3 HU P9900580 A3 HUP9900580 A3 HU P9900580A3 HU 9900580 A HU9900580 A HU 9900580A HU P9900580 A HUP9900580 A HU P9900580A HU P9900580 A3 HUP9900580 A3 HU P9900580A3
Authority
HU
Hungary
Prior art keywords
dichlorobenzimidazole
derivatives
amino
antiviral activity
antiviral
Prior art date
Application number
HU9900580A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HUP9900580A2 publication Critical patent/HUP9900580A2/hu
Publication of HUP9900580A3 publication Critical patent/HUP9900580A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9900580A 1996-01-05 1997-01-03 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity HUP9900580A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600142.5A GB9600142D0 (en) 1996-01-05 1996-01-05 Chemical compounds

Publications (2)

Publication Number Publication Date
HUP9900580A2 HUP9900580A2 (hu) 1999-06-28
HUP9900580A3 true HUP9900580A3 (en) 2000-01-28

Family

ID=10786609

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900580A HUP9900580A3 (en) 1996-01-05 1997-01-03 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity

Country Status (19)

Country Link
US (1) US5998398A (hu)
EP (1) EP0886635A1 (hu)
JP (1) JP2000503017A (hu)
KR (1) KR19990077040A (hu)
CN (1) CN1212683A (hu)
AP (1) AP9801287A0 (hu)
AU (1) AU1438997A (hu)
BR (1) BR9706938A (hu)
CA (1) CA2241893A1 (hu)
CZ (1) CZ212798A3 (hu)
EA (1) EA199800527A1 (hu)
GB (1) GB9600142D0 (hu)
HU (1) HUP9900580A3 (hu)
IS (1) IS4791A (hu)
NO (1) NO983089L (hu)
OA (1) OA10706A (hu)
PL (1) PL327686A1 (hu)
TR (1) TR199801290T2 (hu)
WO (1) WO1997025316A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872742B2 (en) 1996-08-28 2005-03-29 The Procter & Gamble Company Substituted cyclic amine metalloprotease inhibitors
DE69819695D1 (en) 1997-02-13 2003-12-18 Glaxo Group Ltd Benzimidazolderivate
PL338454A1 (en) 1997-07-30 2000-11-06 Univ Michigan Lixofuranosilbenzimidazoles as antiviral agents
AU763356C (en) 1999-12-27 2004-08-26 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
EP1434579B1 (en) 2001-10-09 2011-06-08 Amgen Inc. Imidazole derivatives as antiinflammatory agents
ZA200600424B (en) 2003-08-01 2007-05-30 Genelabs Tech Inc Bicyclic imidazol derivatives against flaviviridae
CA2600570C (en) * 2005-03-14 2011-12-06 Transtech Pharma, Inc. Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
GB201223265D0 (en) 2012-12-21 2013-02-06 Selvita Sa Novel benzimidazole derivatives as kinase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
US4996308A (en) * 1988-03-25 1991-02-26 Merrell Dow Pharmaceuticals Inc. Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
GB8926417D0 (en) * 1989-11-22 1990-01-10 Wellcome Found Heterocyclic compounds
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
JPH03223264A (ja) * 1990-01-30 1991-10-02 Nippon Kayaku Co Ltd 新規なシクロペンタン誘導体及びその製造法
US5248672A (en) * 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
EP0521463A3 (en) * 1991-07-04 1993-04-14 Hoechst Aktiengesellschaft Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
JPH05141464A (ja) * 1991-11-15 1993-06-08 Kajima Corp 積層ゴム支承及び該積層ゴム支承を用いた構造物の振動制御装置
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
SK29197A3 (en) * 1994-09-09 1997-10-08 Wellcome Found Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring, preparation method thereof, pharmaceutical composition and use

Also Published As

Publication number Publication date
CN1212683A (zh) 1999-03-31
EA199800527A1 (ru) 1999-02-25
IS4791A (is) 1998-06-30
GB9600142D0 (en) 1996-03-06
NO983089L (no) 1998-09-01
CA2241893A1 (en) 1997-07-17
KR19990077040A (ko) 1999-10-25
EP0886635A1 (en) 1998-12-30
JP2000503017A (ja) 2000-03-14
BR9706938A (pt) 1999-04-06
AP9801287A0 (en) 1998-09-30
AU1438997A (en) 1997-08-01
HUP9900580A2 (hu) 1999-06-28
US5998398A (en) 1999-12-07
PL327686A1 (en) 1998-12-21
CZ212798A3 (cs) 1998-12-16
WO1997025316A1 (en) 1997-07-17
OA10706A (en) 2001-05-08
TR199801290T2 (xx) 1998-09-21
NO983089D0 (no) 1998-07-03

Similar Documents

Publication Publication Date Title
PL343249A1 (en) Indole derivatives with antiviral activity
PL329177A1 (en) Derivatives of azahexane ehxibiting antiviral activity
ZA987037B (en) Benzylidene-1-3-dihydro-indol-2-one derivatives having anti-cancer activity.
IL125358A0 (en) 5H-thiazolo [3,2-a] pyrimidine derivatives
AU763636C (en) 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity
SI0818454T1 (en) Benzimidazole derivatives with antihistaminic activity
IL133285A0 (en) Benzimidazole derivatives
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
ZA985352B (en) Barbituric acid derivatives with antimetastatic and antitumor activity.
HK1028246A1 (en) Benzimidazole derivatives
ZA9811128B (en) 1,3,8-Triaza-spiro(4,5)decan-4-on derivatives
HUP9900580A3 (en) 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
MXPA99001777A (es) Dihidropirones con actividad antiviral mejorada.
IL125447A0 (en) Modified benzimidazole nucleosides as antiviral agents
EP1033372A4 (en) COMPOSITIONS WITH ANTI-TUMOR ACTIVITY
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
AU7040798A (en) Pyrimidinone-1,3-oxathiolane derivatives with antiviral activity
ZA985870B (en) 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives
ZA986721B (en) Urea derivatives
GB9703060D0 (en) Antiviral benzimidazole derivatives
AU6308798A (en) Benzoxanthene derivatives exhibiting antiviral activity
ZA985559B (en) Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives
ZA979777B (en) Dihydropyrones with improved antiviral activity.
GB9609665D0 (en) Triterpine derivatives with immunosuppressant activity
ZA986820B (en) Luxofuranosyl benzimidazoles as antiviral agents.